Health insurance companies will be looking for consumers to pay more in 2016, according to Kim Holland, director for state affairs for Blue Cross Blue Shield Association, who called demands for lower premiums or monthly fees "unrealistic."
Health insurance companies will be looking for consumers to pay more in 2016, according to Kim Holland, director for state affairs for Blue Cross Blue Shield Association, who called demands for lower premiums or monthly fees "unrealistic."
Ms Holland predicted that healthcare costs would increase next year because a high proportion of individuals who gained health insurance under the Affordable Care Act need expensive medical care that had been delayed in the past. With fewer younger, healthier people signing up for coverage, health insurance companies are finding that they had to spend more to cover the expensive medical bills.
Read more at International Business Times: http://bit.ly/1dhsrEN
COA: An Advocacy Group Born in Crisis Looks Back at 20 Years
March 23rd 2023The Community Oncology Alliance (COA) retains the spirit of an upstart advocacy group, while working to look ahead at innovative technologies, care delivery trends, and other events that threaten independent practices, said oncology leaders while attending their annual meeting this week.
Read More
Experts Call for a More Patient-Focused Approach to Prior Authorization
March 23rd 2023On the first full day of conference activity at AMCP 2023, a morning session examined prior authorization (PA) through a lens of refining the current process and the potential role of clinical trial data in PA criteria.
Read More
Reaching Rural America: Value-Based Care Solutions for Systemic Health and Social Inequalities
March 7th 2023On this episode of Managed Care Cast, we speak with Jennifer Schneider, MD, co-founder and chief executive officer of Homeward, a value-based care provider aiming to improve access to high-quality care in rural communities through tech-enabled clinical services, partnerships with local physicians and health plans, and community-level demographic data.
Listen
Patient Outcomes Improve on Several Fronts Following Treatment for Prurigo Nodularis
March 20th 2023Subanalyses of data from the LIBERTY PN-PRIME and LIBERTY PN-PRIME2 studies illustrate how dupilumab for prurigo nodularis can better patient outcomes, including quality of life and symptom burden.
Read More
2 Clarke Drive
Cranbury, NJ 08512